Search Results - "Oppi, S."

CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL by Gallamini, A., Rossi, A., Patti, C., Picardi, M., Romano, A., Cantonetti, M., Oppi, S., Viviani, S., Bolis, S., Trentin, L., Gini, G., Battistini, R., Chauvie, S., Bertolotti, L., Pavoni, C., Parvis, G., Zanotti, R., Gavarotti, P., Cimminiello, M., Schiavotto, C., Viero, P., Avigdor, A., Tarella, C., Rambaldi, A.

Get full text

Genetic Deletion of Hepatic NCOR1 regulates the bile acid metabolism and leads to reduction in atherosclerosis by Geiger, M, Oppi, S A, Stein, S N, Costantino, S, Mohammed, S A, Ruschitzka, F, Paneni, F, Stein, S

“…Abstract Background The nuclear receptor corepressor 1 (NCOR1) plays an important role in the regulation of gene expression in immunometabolic conditions by…”
Get full text

Deletion of hepatic NCOR1 confers atheroprotection by Oppi, S., Nusser-Stein, S., Lüscher, T.F., Oosterveer, M.H., Stein, S.

Get full text

P1941The nuclear receptor corepressor 1 blocks CD36-mediated foam cell formation in atherogenesis by Oppi, S, Stein, S, Marzolla, V, Osto, E, Rancic, Z, Luscher, T F, Oosterveer, M

“…Abstract Background Nuclear receptors and their cofactors regulate the expression of various target genes in different tissue and organs to orchestrate…”
Get full text

P715Deletion of fibroblast activation protein decreases experimental atherosclerotic plaque formation and vulnerability by Stein, S, Weber, J, Nusser-Stein, S, Pahla, J, Zhang, H, Oppi, S, Staels, B, Gorrell, M D, Luscher, T F, Matter, C M

“…Abstract Background Fibroblast activation protein (FAP) is a serine protease that is upregulated in sites of tissue remodeling, including arthritis, tumors and…”
Get full text

Experimental Drugs for Chemotherapy- and Cancer-Related Anemia by Madeddu, Clelia, Neri, Manuela, Sanna, Elisabetta, Oppi, Sara, Maccio, Antonio

“…Anemia in cancer patients is a relevant condition complicating the course of the neoplastic disease. Overall, we distinguish the anemia which arises under…”
Get full text

Unrelated bone marrow transplantation in thalassemia. The experience of the Italian Bone Marrow Transplant Group (GITMO) by La Nasa, G, Giardini, C, Locatelli, F, Argiolu, F, Vassallo, E, Prete, A, Caocci, G, Floris, R, Garau, P, Littera, R, Mantovani, D, Oppi, S, Piras, E, De Stefano, P, Sanna, M A, Mulargia, M, Carcassi, C, Contu, L

“…Allogeneic bone marrow transplantation (BMT) is a widely accepted therapeutic approach in homozygous beta-thalassemia. However, the majority of patients do not…”
Get full text

BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILURE IN ADVANCED‐STAGE HODGKIN LYMPHOMA WITH A NEGATIVE INTERIM PET SCAN AFTER 2 CHEMOTHERAPY CYCLES. A RETROSPECTIVE ANALYSIS FROM THE GITIL/FIL HD0607 TRIAL by Gallamini, A, Rambaldi, A, Patti, C, Romano, A, Viviani, S, Bolis, S, Oppi, S, Trentin, L, Cantonetti, M, Sorasio, R, Gavarotti, P, Gottardi, D, Schiavotto, C, Battistini, R, Gini, G, Ferreri, Andrès, Pavoni, C, Bergesio, F, Ficola, U, Guerra, L, Chauvie, S

Get full text

PB1894 INFECTIOUS RISK AND HYPOGAMMAGLOBULINEMIA IN A MONOCENTRIC REAL LIFE COHORT OF 211 CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS FOLLOWED FOR 25 YEARS by Murru, R., Caocci, G., Galitzia, A., Uda, S., Culurgioni, F., Oppi, S., La Nasa, G.

“…Background: Infections represent a major contributor to morbidity and mortality in chronic lymphocytic leukaemia (CLL). Hypogammaglobulinemia (HGG) is a common…”
Get full text